$WW $172m rev vs $161m est and Ebitda of $43m vs $29m est.
Crushed it.
Some noise in guidance from accounting change on how advertising expenses will be recognized post BK that will pressure Q4 ebitda and then naturally bolster 2026 since it was shifted into Q4. Explains the lack of a material guide up. Maybe a muted response going forward until more clarity and more evidence of a turn around.
$WW End of qtr clinical subscribers was 124k, estimate by MS was 112k. Material beat there
Now all compounded users have fallen off, they would have zero left.
$WW Nice day, traded 8.8% of all the shares outstanding today, which is 2nd most since emerging from BK.
TexMex retweeted
We sent out our original note on the $WW turnaround post-BK back in August but it's become very apparent that not many people understand the upside here.
The value is in the credit agreement and assuming no upside to projections or the multiple, we're looking at >$25/share of equity value just from deleveraging.
Factor in the market catching wind, and there could be a path for $WW to triple off the current levels.
See our credit agreement explanation and math below.
cedargroveresearch.com/p/ww-…
TexMex retweeted
Remember Paul Lynde? Some of you have no idea who he was. That’s OK, because this has nothing to do with him… but it has everything to do with a different way of looking at the bull thesis on Weight Watchers $WW, via the credit side of the ledger. My latest… herbgreenberg.com/p/a-differ…
$WW $AMZN WeightWatchers doing a lot of things over the last month, definitely locked in and focused on changing the direction of the company. streetinsider.com/Corporate+…
$WW WeightWatchers' next act goes beyond points axios.com/2025/10/16/weightw…
TexMex retweeted
i see what you guys are doing:
*NVIDIA TO INVEST UP TO $100B IN OPENAI
Queen Latifah was on The View yesterday talking up all things regarding $WW and the brand and Menopause. We'll see how this effects subscribers moving forward. abc.com/video/22a00018-b938-… 4:50 mark
Queen Latifah + $WW + Launch of Menopause division wsj.com/articles/weightwatch…
$WW conservative guide is likely putting a damper on the stock this morning. Ridiculously cheap and conservative guidance sets up low expectations for next qtr.
They see clinic business churning through compounded users by end of August since they were on 90 day refills and so subs will decline in Q3. After that $WW is a pureplay on GLP-1's with no compounded users.
At under 5x EV/EBITDA and highly cash flow positive, this is a story that can go bananas with even just a little bit of execution.
Reminds me of $DBD out of bk
Really interesting charts $WW. Thank you!
Replying to @TraderTexMex
$WW At just 10x EV/EBITDA multiple on that guide of $140-150m it would be a $117/share. On $175m EBITDA, more realistic, 2025 EBITDA at 10x multiple it would be worth $147/share.
All financial websites were acting like it had a $3b mkt cap before today since they hadn't had updated SEC filings.



















